论文部分内容阅读
目的:研究分析采用思密达治疗小儿腹泻的用药方式及临床疗效,为其临床治疗提供理论依据。方法:回顾性分析2010年6月-2012年12月期间,我院收治的150例小儿腹泻患者的临床资料,按照患儿入院治疗的时间顺序,以及治疗期间采用的不同临床方案,将150例患者分为两组,对照组患儿75例,治疗期间给予常规临床治疗措施,给予单一金双歧治疗,观察组患儿75例,治疗期间在常规治疗的基础上加用思密达治疗,严格观察患者治疗期间的临床症状,注意其临床疗效情况。结果:治疗后观察组患者的治疗有效率为94.7%,对照组为84.0%,观察组明显优于对照组,两组比较差异明显,具有统计学意义,(P<0.05)。结论:思密达在腹泻患儿的临床治疗中具有重要的意义,能够显著增加患儿治疗依从性,改善患者的临床症状,提高治疗效果,值得临床重视和推广。
Objective: To study and analyze the mode of administration and clinical efficacy of Smectite in the treatment of infantile diarrhea, and to provide a theoretical basis for its clinical treatment. Methods: The clinical data of 150 cases of infantile diarrhea in our hospital from June 2010 to December 2012 were retrospectively analyzed. According to the chronological order of admission to hospital and the different clinical plans adopted during treatment, 150 cases Patients were divided into two groups, control group of 75 children, given routine clinical treatment during treatment, given a single bifidobacterium treatment group of 75 patients in the observation group during treatment based on conventional treatment with Smectite, strict observation Clinical symptoms during treatment of patients, pay attention to their clinical efficacy. Results: After treatment, the effective rate of treatment was 94.7% in the observation group and 84.0% in the control group. The observation group was significantly better than the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Smectite is of great significance in the clinical treatment of children with diarrhea, which can significantly increase the treatment compliance, improve the clinical symptoms and improve the therapeutic effect in children, which deserves clinical attention and promotion.